H-高脯氨酸-OMe盐酸盐 | 18650-39-0

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: H-高脯氨酸-OMe盐酸盐
• 中文别名: (S)-2-哌啶甲酸甲酯(盐酸盐)；L-高脯氨酸甲酯盐酸盐；(S)-哌啶-2-甲酸甲酯；(S)-哌啶-2-甲酸甲酯盐酸盐
• 英文名称: (S)-methyl pipecolinate hydrochloride
• 英文别名: (S)-methyl piperidine-2-carboxylate hydrochloride；methyl (S)-piperidine-2-carboxylate hydrochloride；(S)-piperidine-2-carboxylic acid methyl ester hydrochloride；methyl (2S)-piperidine-2-carboxylate hydrochloride；L(-)-pipecolic acid methyl ester hydrochloride；(2S)-piperidine-2-carboxylic acid methyl ester hydrochloride；methyl L-pipecolate hydrochloride；(S)-pipecolic acid methyl ester hydrochloride；methyl (2S)-piperidin-1-ium-2-carboxylate;chloride
• CAS: 18650-39-0
• 化学式: C₇H₁₃NO₂*ClH
• 分子量: 179.647
• InChiKey: APCHKWZTSCBBJX-RGMNGODLSA-N

物化性质

• 熔点：
  176-177℃

计算性质

• 辛醇/水分配系数(LogP)：
  0.72
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.86
• 拓扑面积：
  38.3
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 海关编码：
  2933399090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: (S)-Piperidine-2-carboxylic acid methyl ester, HCl
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: (S)-Piperidine-2-carboxylic acid methyl ester, HCl
CAS number: 18650-39-0

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H13NO2.ClH
Molecular weight: 179.6

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  H-高脯氨酸-OMe盐酸盐 在 三乙酰氧基硼氢化钠 、 苯甲醛 、 N,N-二异丙基乙胺 作用下， 以 二氯甲烷 为溶剂， 生成 methyl (S)-N-benzylpipecolinate
  参考文献：
  名称：

  Benzhydryl derivatives

  摘要：

  公式（I）的化合物：其中Z、R1、R2、R8、R10、R11、R12、R13和R14如描述中所定义，或其盐。本发明的目标化合物具有如Tachykinin拮抗等药理活性，并可用于制备用于治疗或预防Tachykinin介导疾病的药物。

  公开号：

  US20030176430A1
• 作为产物：
  描述：

  六氢吡啶-alpha-羧酸 在 氯化亚砜 作用下， 以 甲醇 为溶剂， 生成 H-高脯氨酸-OMe盐酸盐
  参考文献：
  名称：

  Benzhydryl derivatives

  摘要：

  公式（I）的化合物：其中Z、R1、R2、R8、R10、R11、R12、R13和R14如描述中所定义，或其盐。本发明的目标化合物具有如Tachykinin拮抗等药理活性，并可用于制备用于治疗或预防Tachykinin介导疾病的药物。

  公开号：

  US20030176430A1

文献信息

• DIHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE AND PHARMACEUTICALS CONTAINING THE SAME
  申请人：CHUGAI SEIYAKU KABUSHIKI KAISHA

  公开号：US20160002251A1

  公开（公告）日：2016-01-07

  The present invention provides a dihydropyridazine-3,5-dione derivative or a salt thereof, or a solvate of the compound or the salt, a pharmaceutical drug, a pharmaceutical composition, a sodium-dependent phosphate transporter inhibitor, and a preventive and/or therapeutic agent for hyperphosphatemia, secondary hyperparathyroidism, chronic renal failure, chronic kidney disease, and arteriosclerosis associated with vascular calcification comprising the compound as an active ingredient, and a method for prevention and/or treatment.

  本发明提供了一种二氢吡啶嗪-3,5-二酮衍生物或其盐，或化合物或盐的溶剂化合物，一种药物，一种药物组合物，一种钠依赖性磷酸盐转运体抑制剂，以及作为活性成分的化合物的高磷血症、继发性甲状旁腺功能亢进症、慢性肾功能衰竭、慢性肾病和与血管钙化相关的动脉硬化的预防和/或治疗剂，以及预防和/或治疗的方法。
• A convenient synthesis of amino acid p-nitroanilides; synthons in the synthesis of protease substrates
  作者：Dirk T.S. Rijkers、Hans P.H.M. Adams、H. Coenraad Hemker、Godefridus I. Tesser

  DOI：10.1016/0040-4020(95)00671-t

  日期：1995.10

  A method is described for the synthesis of Nα-protected bi- and trifunctional amino acid p-nitroanilides. The reaction uses phosphorus oxychloride as the condensing agent. The synthesis is simple, rapid, free of racemization and affords yields between 70–90%. The synthesis can be performed not only with amino acid derivatives of the urethane type including acid-labile (Z. Boc) and base-labile (Fmoc

  一种方法是为N的合成所述α -保护的二-和三官能氨基酸p -nitroanilides。该反应使用三氯氧化磷作为缩合剂。合成简单，快速，没有消旋作用，收率在70-90％之间。可以进行合成不仅与聚氨酯类的氨基酸衍生物，包括酸不稳定（Z. Boc）和碱不稳定的羰基（Fmoc，MSC）N α -proteclivc功能或烯丙基衍生的保护，而且还用N α -三烯丙基氨基酸，尽管收率较低。该反应在吡啶中进行，其机理暗示了通过与二氯二磷酸（HOPOCl 2）形成混合酸酐来进行羧基活化。
• [EN] COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS<br/>[FR] ASSOCIATIONS D'INHIBITEURS DU VIRUS DE L'HÉPATITE C
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2015005901A1

  公开（公告）日：2015-01-15

  The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.

  本公开涉及抗病毒化合物，更具体地涉及能够抑制由丙型肝炎病毒（HCV）编码的NS5A蛋白功能的化合物组合，包括这种组合的组合物，以及抑制NS5A蛋白功能的方法。
• HETEROCYCLIC TRIAZOLE COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR
  申请人：AMGEN INC.

  公开号：US20170320860A1

  公开（公告）日：2017-11-09

  Compounds of Formula I and Formula II, pharmaceutically acceptable salts thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and may have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the following structures: where the definitions of the variables are provided herein.

  公式I和公式II的化合物，其药用盐，上述任何一个的立体异构体，或它们的混合物是APJ受体的激动剂，可能用于治疗心血管和其他疾病。公式I和公式II的化合物具有以下结构： 其中变量的定义在此提供。
• [EN] NOVEL CYTOTOXIC AGENTS FOR CONJUGATION OF DRUGS TO CELL BINDING MOLECULE<br/>[FR] NOUVEAUX AGENTS CYTOTOXIQUES POUR LA CONJUGAISON DE MÉDICAMENTS AVEC LA MOLÉCULE DE LIAISON CELLULAIRE
  申请人：HANGZHOU DAC BIOTECH CO LTD

  公开号：WO2015028850A1

  公开（公告）日：2015-03-05

  Provided are cytotoxic agents, pyrrolo[2,1-c][1,4]benzodiazepine (PBD) derivatives, their conjugates with a cell-binding agent, the preparation and the therapeutic uses in the targeted treatment of cancers, autoimmune disorders, and infectious diseases.

  提供了细胞毒性药物，吡咯并[2,1-c][1,4]苯二氮杂环己烷（PBD）衍生物，它们与细胞结合剂的结合物，以及在靶向治疗癌症、自身免疫性疾病和传染病中的制备和治疗用途。